Pharmacokinetic Study of Di-Phenyl-Di-(2,4-Difluobenzohydroxamato)Tin(IV): Novel Metal-Based Complex with Promising Antitumor Potential

Figure 2

HPLC-DAD profiles of DPDFT in plasma sample. (a) Blank plasma; (b) DPDFT (2 μg·mL⁻¹) standard; (c) blood sample containing DPDFT (2.4 μg·mL⁻¹) collected at 3 min after administration of DPDFT (15 mg·kg⁻¹, i.v.).

(a)

(b)

(c)